Asia Pacific autoimmune disease diagnostics market will grow by 9.7% annually with a total addressable market cap of $19.06 billion over 2022-2031 owing to the growing prevalence of autoimmune diseases, the strong investment in research and development activities, the rise in technological advancements, increasing patient awareness and healthcare expenditure, and favorable government policies.
Highlighted with 35 tables and 70 figures, this 131-page report “Asia Pacific Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific autoimmune disease diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific autoimmune disease diagnostics market in every aspect of the classification from perspectives of Product, Test Type, Disease Type, Gender, Age, End User, and Country.
Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Assay Kits & Consumables
• Analyzers & Instruments
Based on Test Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Autoantibodies and Immunologic Tests
o Antinuclear Antibody Tests
o Anti-cyclic Citrullinated Peptide
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Rheumatoid Factor
o Thyroid Antibody Tests
o Other Autoantibodies and Immunologic Tests
• Inflammatory Marker Tests
o C-Reactive Protein (CRP)
o Erythrocyte Sedimentation Rate (ESR)
o Other Inflammatory Marker Tests
• Routine Laboratory Tests
o Urinalysis
o Complete Blood Count (CBC) Tests
o Other Routine Laboratory Tests
• Other Test Types
Based on Disease Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Systemic Autoimmune Disease
o Rheumatoid Arthritis
o Systemic Lupus Erythematosus (SLE)
o Psoriasis/Psoriatic Arthritis
o Other Systemic Autoimmune Diseases
• Localized Autoimmune Disease
o Thyroiditis
o Multiple Sclerosis
o Inflammatory Bowel Disease
o Type 1 Diabetes
o Other Localized Autoimmune Diseases
Based on Gender, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Female Patients
• Male Patients
Based on Age, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• < 44
• 44 - 64
• > 64
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals
• Clinics
• Diagnostic Labs
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Product, Disease Type, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
Beckman Coulter, Inc.
Biomerieux SA
Bio-rad Laboratories Inc.
F. Hoffmann-la Roche Ltd.
Hemagen Diagnostics Inc.
Myriad Genetics Inc.
PerkinElmer Inc. (Euroimmun AG)
Quest Diagnostics Inc.
Siemens Healthineers Inc.
Thermo Fisher Scientific Inc.
Trinity Biotech PLC
Werfen Company (Inova Diagnostics Inc.)
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter’s Fiver Forces Analysis 37
3 Segmentation of Asia Pacific Market by Product 42
3.1 Market Overview by Product 42
3.2 Assay Kits & Consumables 44
3.3 Analyzers & Instruments 45
4 Segmentation of Asia Pacific Market by Test Type 46
4.1 Market Overview by Test Type 46
4.2 Autoantibodies and Immunologic Tests 48
4.2.1 Antinuclear Antibody Tests 50
4.2.2 Anti-cyclic Citrullinated Peptide 51
4.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) 52
4.2.4 Rheumatoid Factor 53
4.2.5 Thyroid Antibody Tests 54
4.2.6 Other Autoantibodies and Immunologic Tests 55
4.3 Inflammatory Marker Tests 56
4.3.1 C-Reactive Protein (CRP) 58
4.3.2 Erythrocyte Sedimentation Rate (ESR) 59
4.3.3 Other Inflammatory Marker Tests 60
4.4 Routine Laboratory Tests 61
4.4.1 Urinalysis 63
4.4.2 Complete Blood Count (CBC) Tests 64
4.4.3 Other Routine Laboratory Tests 65
4.5 Other Test Types 66
5 Segmentation of Asia Pacific Market by Disease Type 67
5.1 Market Overview by Disease Type 67
5.2 Systemic Autoimmune Disease 69
5.2.1 Rheumatoid Arthritis 71
5.2.2 Systemic Lupus Erythematosus (SLE) 72
5.2.3 Psoriasis/Psoriatic Arthritis 73
5.2.4 Other Systemic Autoimmune Diseases 74
5.3 Localized Autoimmune Disease 75
5.3.1 Thyroiditis 77
5.3.2 Multiple Sclerosis 78
5.3.3 Inflammatory Bowel Disease 79
5.3.4 Type 1 Diabetes 80
5.3.5 Other Localized Autoimmune Diseases 81
6 Segmentation of Asia Pacific Market by Gender 82
6.1 Market Overview by Gender 82
6.2 Female Patients 84
6.3 Male Patients 85
7 Segmentation of Asia Pacific Market by Age 86
7.1 Market Overview by Age 86
7.2 < 44 88
7.3 44 - 64 89
7.4 > 64 90
8 Segmentation of Asia Pacific Market by End User 91
8.1 Market Overview by End User 91
8.2 Hospitals 93
8.3 Clinics 94
8.4 Diagnostic Labs 95
8.5 Other End Users 96
9 Asia-Pacific Market 2021-2031 by Country 97
9.1 Overview of Asia-Pacific Market 97
9.2 Japan 100
9.3 China 103
9.4 Australia 105
9.5 India 107
9.6 South Korea 109
9.7 Rest of APAC Region 111
10 Competitive Landscape 113
10.1 Overview of Key Vendors 113
10.2 New Product Launch, Partnership, Investment, and M&A 116
10.3 Company Profiles 117
Abbott Laboratories 117
Beckman Coulter, Inc. 119
Biomerieux SA 120
Bio-rad Laboratories Inc. 121
F. Hoffmann-la Roche Ltd. 122
Hemagen Diagnostics Inc. 123
Myriad Genetics Inc. 124
PerkinElmer Inc. (Euroimmun AG) 125
Quest Diagnostics Inc. 126
Siemens Healthineers Inc. 127
Thermo Fisher Scientific Inc. 128
Trinity Biotech PLC 129
Werfen Company (Inova Diagnostics Inc.) 130
RELATED REPORTS 131
List of Tables:
Table 1. Snapshot of Asia Pacific Autoimmune Disease Diagnostics Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Health Spending by Region, $ bn, 2013-2020 29
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Autoimmune Disease Diagnostics Market 33
Table 5. Asia Pacific Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 42
Table 6. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, $ mn 46
Table 7. Asia Pacific Autoimmune Disease Diagnostics Market: Autoantibodies and Immunologic Tests by Type, 2021-2031, $ mn 49
Table 8. Asia Pacific Autoimmune Disease Diagnostics Market: Inflammatory Marker Tests by Type, 2021-2031, $ mn 57
Table 9. Asia Pacific Autoimmune Disease Diagnostics Market: Routine Laboratory Tests by Type, 2021-2031, $ mn 62
Table 10. Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 67
Table 11. Asia Pacific Autoimmune Disease Diagnostics Market: Systemic Autoimmune Disease by Type, 2021-2031, $ mn 70
Table 12. Asia Pacific Autoimmune Disease Diagnostics Market: Localized Autoimmune Disease by Type, 2021-2031, $ mn 76
Table 13. Asia Pacific Autoimmune Disease Diagnostics Market by Gender, 2021-2031, $ mn 82
Table 14. Asia Pacific Autoimmune Disease Diagnostics Market by Age, 2021-2031, $ mn 86
Table 15. Asia Pacific Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 91
Table 16. APAC Autoimmune Disease Diagnostics Market by Country, 2021-2031, $ mn 98
Table 17. Japan Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 102
Table 18. Japan Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 102
Table 19. Japan Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 102
Table 20. China Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 104
Table 21. China Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 104
Table 22. China Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 104
Table 23. Australia Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 106
Table 24. Australia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 106
Table 25. Australia Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 106
Table 26. India Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 108
Table 27. India Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 108
Table 28. India Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 108
Table 29. South Korea Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 110
Table 30. South Korea Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 110
Table 31. South Korea Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 110
Table 32. Autoimmune Disease Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 112
Table 33. Abbott Laboratories: Company Snapshot 117
Table 34. Abbott Laboratories: Business Segmentation 118
Table 35. Abbott Laboratories: Product Portfolio 118
